The Tampa-based biotech company has received its second patent of 2019, and its 15th overall, which covers the intellectual property and simulation methodology for its Wearable Chest Tube Medical Skills Trainer
TAMPA, Fla. – SynDaver, an advanced bio-technology company specializing in the creation of synthetic human and animal simulators for medical testing, education and training, announced today that the U.S. Patent and Trademark Office issued U.S. Patent 10,424,226 for the company’s wearable chest tube skills training device.
The patent, which was issued on September 24, 2019, provides protections for the design and manufacturing of SynDaver’s Wearable Chest Tube Skills Trainer. The device is a wearable medical training simulator used to train students to develop skills associated with chest tube placement, which involves inserting a flexible tube into the pleural cavity to drain air, blood, bile, pus or other fluids. This procedure is also known as tube thoracostomy.
Designed to be worn by a patient actor around their upper body, the device is made with an inner protective shield and an outer layer of SynDaver’s proprietary synthetic tissues, called SynTissue®, to ensure unmatched realism in thoracostomy training. Students using the device experience the realistic haptic feedback consistent with a live patient, including appropriate frictional values and puncture resistance.
SynDaver has a history of creating innovative medical simulation technologies and has been awarded 15 U.S. patents since its inception. The company also received a patent for its cricothyroidotomy and nasogastric intubation simulation technology this past July.
“We’re proud to be recognized yet again for the unique and innovative devices being pioneered by SynDaver. Being awarded our 15th patent is an honor and we remain committed to delivering new technologies that help better prepare future generations of medical professionals,” said Dr. Christopher Sakezles, founder and CEO of SynDaver.
The Wearable Chest Tube Skills Trainer weighs five pounds and is small enough to be fitted under a patient actor’s normal clothing. The device simulates a portion of the thorax and includes a combination of highly realistic soft tissues and bone structures backed by ballistics-quality armor to prevent injury to the patient actor.
The trainer is used to enhance simulated exercises for a variety of medical professions, including emergency medical technologists, field medics, flight medics, naval medics, paramedics, first responders, emergency physicians and nurses.
SynDaver’s synthetic humans, animals and task trainers simulate the anatomy of live patients in great detail, including individual muscles, tendons, veins, arteries, nerves and organ systems. The company’s proprietary SynTissue® synthetic tissues are made of water, fibers and salts. Each of these non-toxic, non-latex tissues has been validated against the relevant living tissue for mechanical and physical properties.
For more information about SynDaver or the company’s products, visit https://syndaver.com/.
Headquartered in Tampa, SynDaver is the world’s leading manufacturer of hyper-realistic, synthetic human and animal models for medical education, training and surgical simulation. SynDaver’s synthetic bodies mimic live tissue properties and are used by high schools, colleges and universities, hospitals, medical device companies and the military for training, testing and validation. SynDaver has the world’s largest database of live-tissue properties. Made from a proprietary formula of water, salts and fibers, the company holds 15 patents on their materials, processes and the related products. SynDaver has more than 100 employees at its facilities in the U.S. and is planning additional facilities in Europe, China, Brazil and India. SynDaver products have been lauded by industry experts and earned a cult following after appearances on ABC’s Shark Tank, MythBusters, Grey’s Anatomy and the series finale of CSI. For more information on SynDaver or their product offerings, visit http://SynDaver.com.
For media-related inquiries, please contact our public relations firm at 813.279.8335 or by email at email@example.com.